TURNING TEAMWORK INTO BIOTECH

By Mike May - Guest EditorTURNING TEAMWORK INTO BIOTECHA decade or two ago, North Carolina was known for few things: tobacco farming, furniture building, and the first flight of the Wright brothers. Most of all, North Carolina held a reputation as the training ground for astounding basketball players, including Grant Hill, Michael Jordan, David Thompson, and many others. The cognoscenti, however, imagined a new status for the state. Even as early as the mid-20th century, teams of academic scient

Written byMike May
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A decade or two ago, North Carolina was known for few things: tobacco farming, furniture building, and the first flight of the Wright brothers. Most of all, North Carolina held a reputation as the training ground for astounding basketball players, including Grant Hill, Michael Jordan, David Thompson, and many others. The cognoscenti, however, imagined a new status for the state. Even as early as the mid-20th century, teams of academic scientists, government officials, and industry leaders were working on a new transition, in which science and technology would drive North Carolina's economy.

Forward-thinking leaders in North Carolina's government helped drive this biotech transition, as described in a series of articles starting on here. In September 1956, the Research Triangle Committee started a process that turned forest into future biotech success. With the strong support of three governors and a wide range of industry leaders, today's Research Triangle Park houses more ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies